ABBVIE INC (ABBV) Fundamental Analysis & Valuation
NYSE:ABBV • US00287Y1091
Current stock price
200.5 USD
-4.62 (-2.25%)
At close:
200.801 USD
+0.3 (+0.15%)
After Hours:
This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABBV Profitability Analysis
1.1 Basic Checks
- In the past year ABBV was profitable.
- ABBV had a positive operating cash flow in the past year.
- In the past 5 years ABBV has always been profitable.
- In the past 5 years ABBV always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of ABBV (3.12%) is better than 89.53% of its industry peers.
- With an excellent Return On Invested Capital value of 14.42%, ABBV belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
- ABBV had an Average Return On Invested Capital over the past 3 years of 12.12%. This is significantly below the industry average of 27.75%.
- The 3 year average ROIC (12.12%) for ABBV is below the current ROIC(14.42%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- With an excellent Profit Margin value of 6.84%, ABBV belongs to the best of the industry, outperforming 89.73% of the companies in the same industry.
- In the last couple of years the Profit Margin of ABBV has declined.
- ABBV has a better Operating Margin (34.23%) than 96.51% of its industry peers.
- ABBV's Operating Margin has improved in the last couple of years.
- ABBV's Gross Margin of 71.62% is amongst the best of the industry. ABBV outperforms 81.01% of its industry peers.
- ABBV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. ABBV Health Analysis
2.1 Basic Checks
- ABBV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- ABBV has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for ABBV remains at a similar level compared to 5 years ago.
- Compared to 1 year ago, ABBV has a worse debt to assets ratio.
2.2 Solvency
- ABBV has an Altman-Z score of 2.27. This is not the best score and indicates that ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
- ABBV has a Altman-Z score of 2.27. This is in the better half of the industry: ABBV outperforms 65.70% of its industry peers.
- ABBV has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as ABBV would need 3.79 years to pay back of all of its debts.
- ABBV has a better Debt to FCF ratio (3.79) than 92.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.27 |
ROIC/WACC1.6
WACC9.02%
2.3 Liquidity
- ABBV has a Current Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.67, ABBV is not doing good in the industry: 91.09% of the companies in the same industry are doing better.
- A Quick Ratio of 0.56 indicates that ABBV may have some problems paying its short term obligations.
- ABBV has a Quick ratio of 0.56. This is amonst the worse of the industry: ABBV underperforms 91.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. ABBV Growth Analysis
3.1 Past
- The earnings per share for ABBV have decreased by -1.19% in the last year.
- ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
- The Revenue has grown by 8.57% in the past year. This is quite good.
- ABBV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.95% yearly.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- Based on estimates for the next years, ABBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.08% on average per year.
- Based on estimates for the next years, ABBV will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. ABBV Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.05, ABBV is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 93.22% of the companies listed in the same industry.
- ABBV is valuated rather cheaply when we compare the Price/Earnings ratio to 27.79, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 13.52, the valuation of ABBV can be described as correct.
- Based on the Price/Forward Earnings ratio, ABBV is valued cheaper than 96.71% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 38.88. ABBV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.05 | ||
| Fwd PE | 13.52 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 94.19% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 95.74% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.91 | ||
| EV/EBITDA | 14.53 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ABBV has a very decent profitability rating, which may justify a higher PE ratio.
- ABBV's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%
5. ABBV Dividend Analysis
5.1 Amount
- ABBV has a Yearly Dividend Yield of 3.31%.
- ABBV's Dividend Yield is rather good when compared to the industry average which is at 0.77. ABBV pays more dividend than 99.22% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, ABBV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
5.2 History
- The dividend of ABBV is nicely growing with an annual growth rate of 6.76%!
- ABBV has paid a dividend for at least 10 years, which is a reliable track record.
- ABBV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.76%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
- 278.48% of the earnings are spent on dividend by ABBV. This is not a sustainable payout ratio.
- ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
ABBV Fundamentals: All Metrics, Ratios and Statistics
200.5
-4.62 (-2.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners76.21%
Inst Owner Change0.12%
Ins Owners0.05%
Ins Owner Change6.1%
Market Cap354.64B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target256.12 (27.74%)
Short Float %1.14%
Short Ratio2.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-15 2026-04-15 (1.73)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.17%
PT rev (3m)2.59%
EPS NQ rev (1m)-9.13%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.35%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.05 | ||
| Fwd PE | 13.52 | ||
| P/S | 5.8 | ||
| P/FCF | 19.91 | ||
| P/OCF | 18.64 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.53 |
EPS(TTM)10
EY4.99%
EPS(NY)14.83
Fwd EY7.4%
FCF(TTM)10.07
FCFY5.02%
OCF(TTM)10.76
OCFY5.37%
SpS34.58
BVpS-1.85
TBVpS-51.76
PEG (NY)0.42
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.27 |
F-Score8
WACC9.02%
ROIC/WACC1.6
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / ABBV Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
What is the valuation status for ABBV stock?
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.
What is the profitability of ABBV stock?
ABBVIE INC (ABBV) has a profitability rating of 7 / 10.
What is the valuation of ABBVIE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 20.05 and the Price/Book (PB) ratio is -108.45.
Is the dividend of ABBVIE INC sustainable?
The dividend rating of ABBVIE INC (ABBV) is 7 / 10 and the dividend payout ratio is 278.48%.